DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a new functional resourcing strategy delivered by a dedicated division, DOCS. DOCS has been a leading provider of resourcing services to the global biopharmaceutical and medical device industry for over 15 years. To meet the growing demand for FSP solutions, DOCS has developed the FSP Delivery Platform™. This combines DOCS’ global resourcing engine with the processes, quality oversight, systems, and training and governance structures to drive productivity through flexible FSP models. The DOCS FSP Delivery Platform™ also leverages ICON’s extensive therapeutic, geographic and functional expertise to ensure greater efficiencies across customer programs.
